Join

or

Existing user? Login

Community pharmacy

Community pharmacy: the revolution has begun

The proposals put forward in the new community pharmacy contract require a major transition if the sector is going to reap the rewards. 

CONTRACT

Source: Shutterstock.com / JL

In recent years, an over-reliance on dispensing funding for community pharmacy has held back the sector’s development. But that could be all set to change.

In his foreword to the new community pharmacy contract, health secretary Matt Hancock promises a “fundamental shift towards clinical service delivery” and, to some degree, his words are backed up in the subsequent pages.

But there are many parts of this five-year deal — which was published on 22 July 2019 and agreed with the Pharmaceutical Services Negotiating Committee — that may prove a difficult pill to swallow for business owners. In particular, the decision to freeze overall investment in the sector at £2.59bn until 2024, while gradually shrinking the level of funding for dispensing over time by an unspecified amount.

With inflation running at around 2% and many pharmacy contractors already operating their dispensing activity at a loss, this news may cause considerable pain. The hundreds of store closures announced by multiple pharmacy chains over the past few months may be a foreshadowing of an even greater retraction of the sector from high streets across the country — indeed, the document itself explicitly says that there are too many pharmacies “than may be necessary” and says it will encourage greater consolidation.

Another attempt to change the law on hub and spoke dispensing may also cause controversy, and the contract’s proposal of legislative changes to “better use the skill mix in pharmacies” may set alarm bells ringing. Some of the more specific requirements buried in the small print seem slightly bizarre – such as the new incentive for community pharmacies to cut back on the volume of sugary drinks they sell.

However, the major shift in the new framework comes in the amount of funding allocated to clinical services. Over the next five years, funding will be more than doubled from around 4% of current funding to around 11% by 2024. The sector has been crying out for this decision in recent years, with multiple policy documents published by pharmacy organisations calling for a more clinical role for community pharmacy.

Potentially groundbreaking in-pharmacy clinical services will undergo testing, with those deemed successful to be ‘mainstreamed’ through primary care networks

The proposals also include plans for all pharmacies to become ‘healthy living pharmacies’, meaning they will have the capacity to deliver smoking cessation and weight management interventions. They also outline plans for the new medicines service to be expanded to include further indications, while pharmacies could increasingly become the recipients of referrals for minor ailments from all corners of urgent care.

Meanwhile, potentially groundbreaking in-pharmacy clinical services will undergo testing, with those deemed successful to be ‘mainstreamed’ through primary care networks. The document says these may include detecting undiagnosed cardiovascular disease; routine monitoring of women taking oral contraception; and point-of-care testing for colds and flu. If some, although not all, of these services become incorporated into the everyday work of community pharmacy, it will mark a major turning point in the sector. 

There are the first stirrings of a sea change here. If Hancock is to be believed, patients will increasingly be directed to their pharmacy for care and they will see a greater range of NHS services provided there. The only brake on this will be the ability of community pharmacy to incorporate new technology and efficiencies in their dispensing function, while funding is – in real terms – falling. This is in marked contrast to and Scotland, where community pharmacies have received a boost in funding in order to provide more NHS services.

Much of the funding for clinical services is in the “unallocated” column of the breakdown in the document, which is going to prove difficult for pharmacy owners to plan for.

However, there is much to welcome in this contract and greater clarity on the future destination of the sector within the NHS was badly needed. Nevertheless, the transition phase for community pharmacy is going to be tough.

Citation: Electronicjuice DOI: 10.1211/PJ.2019.20206862

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Integrated Pharmacy Case Studies

    Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.

    £47.00
  • Pharmacy and the US Health Care System

    A complete source of current information about the US health care system. Includes concise reports on trends, regulations, policy and finances.

    £49.00
  • Physicochemical Principles of Pharmacy

    This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.

    £48.00
  • Clinical Pharmacy Pocket Companion

    An A-Z pocket book containing concise and practical pharmaceutical information for busy clinical pharmacists.

    £33.00
  • Introduction to Pharmaceutical Calculations

    Introduction to Pharmaceutical Calculations is an essential study aid for pharmacy students. The book contains worked examples and sample questions and answers.

    £33.00

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.